Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.7.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2016
STOCK-BASED COMPENSATION  
Schedule of stock-based compensation expense related to all of the entity's share-based awards

Total stock‑based compensation expense related to all of our stock‑based awards was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

 

2016

    

2015

    

2014

 

General and administrative

 

 

$

4,230

 

$

3,303

 

$

5,113

 

Research and development

 

 

 

3,103

 

 

4,100

 

 

4,674

 

Restructuring charges

 

 

 

499

 

 

 —

 

 

 —

 

Total stock-based compensation expense

 

 

$

7,832

 

$

7,403

 

$

9,787

 

 

Summary of weighted-average assumptions relating to options granted pursuant to equity incentive plans

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

 

December 31,

 

 

    

    

2016

    

2015

    

2014

 

Risk-free interest rate

 

 

1.8

%  

1.8

%  

2.2

%

Expected term (in years)

 

 

6.2

 

6.5

 

6.5

 

Dividend yield

 

 

0.0

%  

0.0

%  

0.0

%

Expected volatility

 

 

61.1

%  

65.0

%  

74.4

%

 

Schedule of option activity under equity incentive plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

    

 

 

    

Weighted-

    

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

Shares Available

 

Number of Shares

 

Weighted-Average

 

Contractual Term

 

Aggregate

 

 

 

For Grant

 

Underlying Options

 

Exercise Price

 

(in years)

 

Intrinsic Value

 

Outstanding at January 1, 2016

 

5,245,977

 

19,106,472

 

$

7.08

 

 

 

 

 

 

Authorized for grant

 

2,790,000

 

 

 

 

 

 

 

 

 

 

Granted

 

(5,251,185)

 

5,251,185

 

$

2.98

 

 

 

 

 

 

Exercised

 

 

(336,520)

 

$

2.30

 

 

 

 

 

 

Cancelled

 

3,763,904

 

(3,763,904)

 

$

6.32

 

 

 

 

 

 

Outstanding at December 31, 2016

 

6,548,696

 

20,257,233

 

$

6.24

 

5.04

 

$

727,727

 

Vested and expected to vest at December 31, 2016

 

 

 

20,032,758

 

$

6.27

 

 

 

 

 

 

Exercisable at December 31, 2016

 

 

 

16,588,341

 

$

6.93

 

4.11

 

$

696,655

 

 

Schedule of stock options by exercise price

Details of our stock options by exercise price are as follows as of December 31, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

    

Number of

    

Weighted-Average

    

 

 

    

 

    

 

 

 

 

 

Outstanding

 

Remaining

 

Weighted-Average

 

Number of

 

Weighted-Average

 

Exercise Price

 

Options

 

Contractual Life (in years)

 

Exercise Price

 

Options

 

Exercise Price

 

$1.68 - $2.54

 

3,638,849

 

6.65

 

$

2.20

 

3,036,017

 

$

2.15

 

$2.72 - $3.20

 

3,387,562

 

7.41

 

 

2.86

 

1,822,751

 

 

2.95

 

$3.26 - $3.92

 

3,505,077

 

7.11

 

 

3.65

 

2,010,617

 

 

3.57

 

$3.96 - $6.55

 

3,551,425

 

3.67

 

 

6.33

 

3,544,637

 

 

6.33

 

$6.73 - $9.62

 

4,270,760

 

3.17

 

 

8.06

 

4,270,760

 

 

8.06

 

$9.74 - $26.45

 

1,903,560

 

0.70

 

 

20.49

 

1,903,560

 

 

20.49

 

$1.68 - $26.45

 

20,257,233

 

5.04

 

 

6.24

 

16,588,342

 

 

6.93

 

 

Summary of weighted-average assumptions used to calculate fair value of purchase rights granted under Employee Stock Purchase Plan

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

December 31,

 

 

    

2016

    

2015

    

2014

 

Risk-free interest rate

 

0.5

%  

0.6

%  

0.3

%

Expected term (in years)

 

1.5

 

1.5

 

1.7

 

Dividend yield

 

0.0

%  

0.0

%  

0.0

%

Expected volatility

 

62.9

%  

61.2

%  

66.0

%